1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Relapsing Multiple Sclerosis (RMS): new trials by email Literature Review of Relapsing Multiple Sclerosis (RMS) trials Research Report on Relapsing Multiple Sclerosis (RMS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Cladribine Tablets on the PK of Microgynon® Cladribine, Placebo, Microgynon® - Relapsing Multiple Sclerosis (RMS) | Phase 1 | Completed | Merck KGaA, Darmstadt, Germany | 28 | 2019-01-17 | 2024-03-15 |
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1)
Cladribine (1) · ethinyl estradiol, levonorgestrel drug combination (1)
Merck KGaA, Darmstadt, Germany (1)
Germany (1) · Poland (1)
2018 (1)